Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,402
  • Shares Outstanding, K 12,600
  • Annual Sales, $ 8,880 K
  • Annual Income, $ -15,830 K
  • 60-Month Beta 2.27
  • Price/Sales 7.75
  • Price/Cash Flow N/A
  • Price/Book 10.71
Trade EKSO with:

Options Overview

Details
  • Implied Volatility 130.05%
  • Historical Volatility 90.06%
  • IV Percentile 70%
  • IV Rank 33.57%
  • IV High 212.88% on 12/04/20
  • IV Low 88.19% on 04/08/21
  • Put/Call Vol Ratio 0.38
  • Today's Volume 113
  • Volume Avg (30-Day) 883
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 5,854
  • Open Int (30-Day) 3,588

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.24
  • Number of Estimates 1
  • High Estimate -0.24
  • Low Estimate -0.24
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.02 +3.59%
on 04/19/21
7.17 -27.47%
on 04/12/21
-1.66 (-24.20%)
since 03/19/21
3-Month
5.02 +3.59%
on 04/19/21
14.98 -65.29%
on 02/08/21
-3.65 (-41.24%)
since 01/20/21
52-Week
2.80 +85.71%
on 05/14/20
14.98 -65.29%
on 02/08/21
+1.75 (+50.72%)
since 04/20/20

Most Recent Stories

More News
Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities

, /PRNewswire/ -- The report has been added to offering.

AHKSF : 11.1700 (-2.62%)
BSX : 41.13 (+0.61%)
EW : 89.63 (+1.21%)
EKSO : 5.20 (-1.33%)
MDSY : 0.73 (+4.29%)
MDT : 128.28 (+1.70%)
Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?

Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...

EKSO : 5.20 (-1.33%)
Rehabilitation Robots Market Size 2021 | Is Projected to Reach USD 2,617.3 Million by 2026, exhibiting a CAGR of 22.1% during the forecast period 2019-2026

Global Rehabilitation robots market 2021 is anticipated to gain momentum from a rise in geriatric population across the globe. According to a published report by Fortune Business Insights, titled, "Rehabilitation...

EKSO : 5.20 (-1.33%)
RWLK : 1.7000 (-4.49%)
Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced a partnership with U.S. Physiatry (USP) to educate...

EKSO : 5.20 (-1.33%)
Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO(TM) Technology

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced that Performance Contracting, Inc. ("PCI"), a leading...

EKSO : 5.20 (-1.33%)
Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer, will present at the H.C....

EKSO : 5.20 (-1.33%)
Ekso Bionics: 4Q Earnings Snapshot

RICHMOND, Calif. (AP) _ Ekso Bionics Holdings Inc. (EKSO) on Thursday reported a loss of $4 million in its fourth quarter.

EKSO : 5.20 (-1.33%)
Ekso Bionics Reports Fourth Quarter and Year End 2020 Results

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months...

EKSO : 5.20 (-1.33%)
Ekso Bionics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25,...

EKSO : 5.20 (-1.33%)
Neurorehabilitation Devices Market Size to Garner USD 2,274.1 Million Revenue by 2025 at Substantial CAGR of 16.4%, Asserts Market Research Future (MRFR)

Neurorehabilitation Devices Market Overview:

BNKL : 2.7500 (+21.68%)
EKSO : 5.20 (-1.33%)
RWLK : 1.7000 (-4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

3rd Resistance Point 5.43
2nd Resistance Point 5.34
1st Resistance Point 5.27
Last Price 5.20
1st Support Level 5.11
2nd Support Level 5.02
3rd Support Level 4.95

See More

52-Week High 14.98
Fibonacci 61.8% 10.33
Fibonacci 50% 8.89
Fibonacci 38.2% 7.45
Last Price 5.20
52-Week Low 2.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar